This report explores the opportunity for Ausmed, an Australian Pharma company, to expand their business operations in China and South Africa. The report includes an analysis of the risks and opportunities in both countries, selection of the country, and proposing and selecting market entry strategy. The report concludes that licensing will be a suitable mode of entry for the Ausmed, an Australian Pharma company.